Revvity and Element Biosciences Collaborate to Advance Sequencing-based IVD Neonatal Testing Jan 13, 2025 08:00AM
Revvity Announces Financial Results for the Second Quarter of 2023 Aug 1, 2023 06:00AM
Revvity Board Declares Quarterly Dividend Jul 21, 2023 04:05PM
Revvity Accelerates NGS Library Prep with Introduction of New Fontus Automated Liquid Handling Workstation at 2023 AACC Jul 20, 2023 08:00AM
Revvity to Hold Earnings Call on Tuesday, August 1, 2023 Jul 12, 2023 08:00AM


Jun 29, 2023 08:00AM Honeycomb Biotechnologies and Revvity Launch New Solutions to Expand the Frontiers of Single Cell Research
Jun 12, 2023 08:00AM Revvity Launches First Scientific SaaS Platform to Accelerate Drug and Materials Development
Jun 1, 2023 09:00AM Revvity’s EUROIMMUN Spearheads Cutting-Edge Diagnostic Analysis with New Automated IIFT System
May 24, 2023 08:00AM Revvity to Present at Goldman Sachs Global Healthcare Conference
May 18, 2023 06:00AM Revvity Announces New License Agreement for Next-Generation Base Editing Technology
May 11, 2023 06:00AM Revvity Announces Financial Results for the First Quarter of 2023
May 9, 2023 08:00AM Launching Revvity: A Scientific Solutions Company Powering Innovation from Discovery to Cure
Feb 24, 2023 06:06AM PerkinElmer Launches EnVison Nexus Multimode Plate Reader to Drive Improved Research and Discovery Workflows
Feb 14, 2023 06:00AM PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2022
Jan 9, 2023 04:05PM PerkinElmer To Hold Earnings Call on Tuesday, February 14, 2023; Updates Fourth Quarter Outlook
Nov 21, 2022 07:00AM PerkinElmer Helps Accelerate Gene Therapy Research with Industry-First Ready-to-Use Viral Vector Assays
Nov 14, 2022 08:03AM PerkinElmer (PKI) Announces FDA Marketing Authorization for EONIS SCID-SMA Kit
Nov 14, 2022 08:00AM PerkinElmer Announces its EONIS SCID-SMA Kit is First to Receive Marketing Authorization by U.S. FDA for SMA Screening in Newborns
Nov 8, 2022 06:00AM PerkinElmer Announces Financial Results for the Third Quarter of 2022
Nov 7, 2022 08:00AM PerkinElmer Bolsters Sustainability Commitments and Builds Off Recent Progress in New ESG Report
Nov 1, 2022 09:00AM EPIC SCIENCES EXPANDS EXECUTIVE TEAM AND WELCOMES NEW CHIEF FINANCIAL OFFICER IN PREPARATION FOR RAPID GROWTH
Oct 17, 2022 07:11AM PerkinElmer (PKI) Updates Third Quarter Outlook
Oct 17, 2022 07:00AM PerkinElmer to Hold Earnings Call on Tuesday, November 8, 2022; Updates Third Quarter Outlook
Oct 13, 2022 08:15AM PerkinElmer Donation Helps Significantly Expand Capacity for Sickle Cell Disease Screening in Ghana
Sep 26, 2022 07:11AM PerkinElmer Unveils Industry-first Cell Analysis Solution to Streamline Cell and Gene Therapy Research and Manufacturing
Sep 22, 2022 08:01AM PerkinElmer's (PKI) Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection
Sep 22, 2022 08:00AM PerkinElmer’s Oxford Immunotec Receives U.S. FDA Approval for T-Cell Select to Automate Clinically Superior Tuberculosis Detection
Aug 17, 2022 08:01AM PerkinElmer (PKI) Names New CFO
Aug 17, 2022 08:00AM PerkinElmer Announces Finance Leadership Transition
Aug 1, 2022 06:18AM New Mountain Capital Announces Intent to Acquire PerkinElmer’s Applied, Food and Enterprise Services Businesses for up to $2.45 Billion
Aug 1, 2022 06:13AM PerkinElmer (PKI) Reports Q2 Revenue of $1.23B, EPS of $1.42
Aug 1, 2022 06:12AM PerkinElmer Announces Financial Results for the Second Quarter of 2022
Aug 1, 2022 06:11AM PerkinElmer (PKI) to Divest Applied, Food and Enterprise Services for $2.45B Cash
Aug 1, 2022 06:10AM PerkinElmer Accelerates Transformation into High Growth, High Margin Life Sciences & Diagnostics Company
Jul 22, 2022 04:11PM PerkinElmer (PKI) Appoints Michelle McMurry-Heath to its Board
Jul 22, 2022 04:10PM PerkinElmer Elects Dr. Michelle McMurry-Heath to its Board of Directors
Jun 21, 2022 07:00AM PerkinElmer Introduces Next Generation, Automated Gas Chromatography Platform
Jun 6, 2022 08:00AM PerkinElmer Launches BioQule NGS System to Automate Library Preparation
May 3, 2022 04:05PM PerkinElmer Announces Financial Results for the First Quarter of 2022
Apr 7, 2022 06:00AM PerkinElmer Expands In Vivo Instruments Portfolio with Hands-free, High-throughput Vega® Widefield Preclinical Ultrasound Imaging System
Apr 4, 2022 08:07AM PerkinElmer Introduces First Ready-to-use HTRF® and AlphaLISA® Assay Kits for CHO HCP Impurities Detection and Quantification
Feb 3, 2022 08:02AM PerkinElmer's (PKI) EUROIMMUN Cited by CDC in its Two-Step Testing Algorithm for Dengue Virus
Feb 3, 2022 08:00AM U.S. Centers for Disease Control Guidance Includes EUROIMMUN Assay in its Two-Step Testing Algorithm for Dengue Virus
Feb 1, 2022 04:05PM PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2021
Oct 31, 2017 04:15PM Phase II Clinical Trial Data Establishes Effectiveness of using a Child’s Own Cord Blood to Treat Cerebral Palsy
Apr 5, 2017 11:01AM Phase I Clinical Trial Examines Safety of Using Cord Blood Stem Cells for Treating Children with Autism Spectrum Disorder
Dec 22, 2016 08:15AM Varian Medical Systems Announces Agreement to Acquire PerkinElmer's Medical Imaging Business; $276 Million Acquisition to Expand Digital Flat Panel Business for Varex Imaging
Aug 20, 2010 12:33PM Highlights From CRM's Q2 Conference Call: Continued Demand Shift to Enterprise Cloud Computing